Jasper Therapeutics (JSPR) Misses Q4 EPS by 32c
Tweet
Share
E-mailGet Alerts JSPR Hot Sheet
Join SI Premium – FREE
Jasper Therapeutics (NASDAQ: JSPR) reported Q4 EPS of ($0.32).
For earnings history and earnings-related data on Jasper Therapeutics (JSPR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- Honda and Nissan to jointly develop vehicle sofware, Nikkei reports
- AiRWA receives Nasdaq deficiency notice over late 10-K filing
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
